Akèy › Maladi Greff-versus-host › Michigan
Etid klinik pou Maladi Greff-versus-host nan Michigan
5 etid pou Maladi Greff-versus-host ap chèche patisipan nan sit nan Michigan.
Vil nan Michigan
Tèks ofisyèl etid la (Anglè)
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Barbara Ann Karmanos Cancer Institute, Detroit
Ap rekriteFaz 2
Laj 2 ak plis · Tout sèks · Mizajou Jun 16, 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of Michigan, Ann Arbor
- Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT06615050PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
- Henry Ford Hospital, Detroit
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Feb 24, 2026 · NCT04886726A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Henry Ford Cancer Institute, Detroit
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06619561Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
- The University of Michigan Cancer Center, Ann Arbor
Ap rekriteEtid obsèvasyon
36 Months · Tout sèks · Mizajou Oct 20, 2025 · NCT05866302Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.